Home | News | Directories | Calendar | Maps | Contact Us | Webmail
Perelman School of Medicine at the University of Pennsylvania Advanced Search

Adam D Cohen, MD

Adam D Cohen, MD

faculty photo
Assistant Professor of Medicine at the Hospital of the University of Pennsylvania
Department: Medicine

Contact information
Perelman Center for Advanced Medicine
12th Floor, South Pavilion
Office #12-154
3400 Civic Center Blvd
Philadelphia, PA 19104
Office: 215-615-5853
Fax: 215-615-5887
Education:
BA
Harvard University, 1994.
MD
University of Pennsylvania, 1999.
Permanent link
 
Perelman School of Medicine > Faculty > Search

Description of Clinical Expertise

Multiple Myeloma
Amyloidosis
POEMS syndrome
Monoclonal gammopathies
Waldenstrom's Macroglobulinemia

Description of Research Expertise

Cancer immunotherapy
Vaccines
Cellular therapy
Phase I trials

Selected Publications

Raje N, Faber E, Richardson P, Schiller G, Hohl R, Cohen AD, Forero A, Carpenter S, Nguyen T, Conti I, Kaiser C, Cronier D, Wooldridge J, Anderson K: Phase 1 study of tabalumab, a human anti-B-cell activating factor antibody, and bortezomib in patients with relapsed/refractory multiple myeloma. Clinical Cancer Research 22: 5688-5695, 2016.

Adam D. Cohen, Alfred L. Garfall, Edward A Stadtmauer, Simon Francis Lacey, Eric Lancaster, Dan T. Vogl, Karen Dengel, David E Ambrose, Fang Chen, Gabriela Plesa, Irina Kulikovskaya, Vanessa E Gonzalez, Minnal Gupta, Regina M Young, Tenesia Carey, Regina Ferthio, Brendan M. Weiss, Celeste Richardson, Randi E. Isaacs, J. Joseph Melenhorst, Bruce L. Levine, Carl H June, Michael C. Milone: B-Cell Maturation Antigen (BCMA)-Specific Chimeric Antigen Receptor T Cells (CART-BCMA) for Multiple Myeloma (MM): Initial Safety and Efficacy from a Phase I Study Blood (ASH Annual Meeting) 128: #1147, 2016 Notes: oral.

Muzaffar H. Qazilbash, Edward A Stadtmauer, Veera Baladandayuthapani, Heather Lin, Beryl M. Tross, Medhavi Honhar, Soung-Chul Cha, Kunhwa Kim, Sheetal S Rao, Michael Popescu, Nina Shah, Qaiser Bashir, Krina Patel, Elizabeth J. Shpall, Donna M. Weber, Sheeba K. Thomas, Jatin J. Shah, Robert Z. Orlowski, Naseem DS Kerr, Alfred L. Garfall, Adam D. Cohen, Karen Dengel, Carl H June, Richard E. Champlin, Larry Kwak: Randomized Phase II Trial of Combination Idiotype Vaccine and Anti-CD3/Anti-CD28 Costimulated Autologous T Cells in Patients with Multiple Myeloma Post-Autotransplantation Blood (ASH Annual Meeting) 128: #4548, 2016.

Lesokhin AM, Ansell SM, Armand P, Scott EC, Halwani A, Gutierrez M, Millenson MM, Cohen AD, Schuster SJ, Lebovic D, Dhodapkar M, Avigan D, Chapuy B, Ligon AH, Freeman GJ, Rodig SJ, Cattry D, Zhu L, Grosso JF, Shipp MA, Borello I, Timmerman J. : Safety, Pharmacokinetics, Immunoregulatory and Preliminary Antitumor Activity of Nivolumab in Patients with Relapsed or Refractory Hematologic Malignancy. Journal of Clinical Oncology 34: 2698-2704, 2016.

Adam D. Cohen, Rakesh Popat, Suzanne Trudel, Paul G Richardson, Ed N. Libby III, Nikoletta Lendvai, Larry D. Anderson Jr., Heather J. Sutherland, Stephen DeWall, Catherine E Ellis, Zangdong He, Jolly Mazumdar, Catherine Wang, Joanna B. Opalinska, Peter M. Voorhees: First in Human Study with GSK2857916, an Antibody Drug Conjugated to Microtubule-Disrupting Agent Directed Against B-Cell Maturation Antigen (BCMA) in Patients with Relapsed/Refractory Multiple Myeloma (MM): Results from Study BMA117159 Part 1 Dose Escalation Blood (ASH Annual Meeting) 128: #1148, 2016 Notes: oral.

Adam D. Cohen, Heather Landau, Emma C. Scott, Michaela Liedtke, Jonathan L. Kaufman, Michael Rosenzweig, Cristina Gasparetto, David H. Vesole, Vaishali Sanchorawala, Suzanne Lentzsch, Christina L. Gomes, Raymond L. Comenzo, Brian G.M. Durie: Safety and Efficacy of Carfilzomib (CFZ) in Previously-Treated Systemic Light-Chain (AL) Amyloidosis Blood (ASH Annual Meeting) 128: #645, 2016 Notes: oral.

Brendan M. Weiss, Sigrun H Lund, Magnus Bjorkholm, Adam D. Cohen, Laura Dember, Ola Landgren, Sigurdur Y Kristinsson: Improved Survival in AL Amyloidosis: A Population-Based Study on 1,430 Patients Diagnosed in Sweden 1995-2013. Blood (ASH Annual Meeting) 128: #4448, 2016.

Alex Ganetsky, Noelle V Frey, Alison W Loren, Elizabeth O. Hexner, James K Mangan, Saar I Gill, Selina Luger, Adam D. Cohen, Daria V Babushok, Edward A Stadtmauer, Jacqueline Smith, William R. Drobyski, Sarah K Kraus, Colleen Timlin, David L. Porter: Tocilizumab Is Highly Active for Severe Steroid-Refractory Acute Graft-Versus-Host Disease of the Gastrointestinal Tract Blood (ASH Annual Meeting) 128: #2245, 2016.

Alfred L. Garfall, Eric Lancaster, Edward A Stadtmauer, Simon F. Lacey, Karen Dengel, David E Ambrose, Fang Chen, Minnal Gupta, Irina Kulikovskaya, Dan T. Vogl, Gabriela Plesa, Brendan M Weiss, Regina Ferthio, Celeste Richardson, Jan Joseph Melenhorst, Bruce L Levine, Carl H June, Michael Milone, Adam D. Cohen: Posterior Reversible Encephalopathy Syndrome (PRES) after Infusion of Anti-Bcma CAR T Cells (CART-BCMA) for Multiple Myeloma: Successful Treatment with Cyclophosphamide Blood (ASH Annual Meeting) 128: #5702, 2016.

Lilly Wilson, Adam D. Cohen, Brendan M. Weiss, Dan T. Vogl, Alfred L. Garfall, Donna L. Capozzi, Patricia Mangan, Mary Sanchez, Colleen Erb, Edward Stadtmauer: Pembrolizumab in Combination with Pomalidomide and Dexamethasone (PEMBRO/POM/DEX) for Pomalidomide Exposed Relapsed or Refractory Multiple Myeloma. Blood (ASH Annual Meeting) 128: #2119, 2016.

back to top
Last updated: 12/15/2016
The Trustees of the University of Pennsylvania